In our previous studies, we have characterized the conformational landscapes of ABL, EGFR, RET and MET kinases as well as various cancer mutants using MD simulations of the Apo kinase and complexes with ATP and small molecule inhibitors [132], [134], [136]. The gene discussed is MET; the disease is cancer.